| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.024 | 0.4 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.4 |